Herantis Pharma Oyj
HRTIS | FN
Overview
Corporate Details
- ISIN(s):
- FI4000087861
- LEI:
- 743700W4CQVYAT3WKK38
- Country:
- Finland
- Address:
- Bertel Jungin Aukio 1, FI-02600 ESPOO
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Herantis Pharma Oyj develops treatments for neurodegenerative diseases like Parkinson's. Their research focuses on regenerative medicine and disease modification.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX |